LARA KING: Open Payments
NPI 1679857932 · MERIDIAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,502 in 37 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $653 · 2025 $4,502
Speaker / faculty: $3,700Food & beverage: $802
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 10 | $3,700 |
| Corcept Therapeutics | 8 | $242 |
| AstraZeneca Pharmaceuticals LP | 3 | $224 |
| Abbott Laboratories | 4 | $114 |
| Novo Nordisk Inc | 4 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| Averitas Pharma Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $20 |
| Medtronic, Inc. | 1 | $18 |
| Blue Earth Diagnostics | 1 | $18 |
Products named: OMNIPOD, Korlym, FARXIGA, FREESTYLE LIBRE 3, BREZTRI, Kerendia, Ozempic, QUTENZA.
Industry payments across MS — which companies pay providers there.
